Oncopia Therapeutics, Inc.

United States of America

Create a watch for Oncopia Therapeutics, Inc.
Total IP 33
Total IP Rank # 44,116
IP Activity Score 2.6/5.0    54
IP Activity Rank # 13,267
Dominant Nice Class Scientific and electric apparatu...

Patents

Trademarks

6 1
1 1
23 1
0
 
Last Patent 2025 - Bicyclic heteroaryl-containing c...
First Patent 2023 - Cereblon ligands and uses thereof
Last Trademark 2023 - MOPED
First Trademark 2022 - MOPED

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Compounds and compositions as smarca2/4 degraders and uses thereof. Described herein are compound...
Invention Compounds and compositions as cbp/p300 degraders and uses thereof. Described herein are compound...
Invention Compounds and compositions as cbp/p300 degraders and uses thereof. Described herein are compounds...
Invention Methods of identifying compounds for inducing protein-protein interaction. The present disclosure...
Invention Compounds and compositions as cereblon ligands and uses thereof. e.g.,e.g., as cereblon-binding a...
Invention Compounds and compositions as cbp/p300 degraders and uses thereof. e.g.,e.g., for degrading certa...
Invention Compounds and compositions as stat3 degraders and uses thereof. Described herein are compounds of...
2023 Invention Cereblon ligands and uses thereof. e.g.,e.g., as cereblon-binding agents or bifunctional degrader...
Invention Cereblon ligands and uses thereof. Described herein are compounds of Formula II or conjugates of ...
Invention Compounds and compositions as smarca2/4 inhibitors and uses thereof. Described herein are compoun...
Invention Cereblon ligands and uses thereof. Described herein are compounds or conjugates of of Formulae I...
Invention Indazole derivatives as estrogen receptor degraders. Described herein are compounds of Formula I ...
Invention Tetrahydronaphthalene derivatives as estrogen receptor degraders. Described herein are compounds ...
Invention Indole derivatives as estrogen receptor degraders. Described herein are compounds of Formula I an...
Invention Chroman derivatives as estrogen receptor degraders. Described herein are compounds of Formula (I)...
Invention Tetrahydronaphthalene derivatives as estrogen receptor degraders
Invention Cereblon ligands and uses thereof. Described herein are compounds and conjugates of Formulae I an...
Invention Cereblon ligands and uses thereof. Described herein are compounds or conjugates of Formulae II an...
Invention Methods of identifying compounds for inducing protein-protein interaction. The present disclosur...
Invention Ikzf2 degraders and uses thereof. Described herein are compounds of Formulae I' and their pharmac...
Invention Bicyclic heteroaryl-containing compounds as ikzf2 degraders. Described herein are compounds of F...
Invention Ikzf2 degraders and uses thereof. Described herein are compounds of Formulae I′ and their pharma...
Invention Cereblon ligands and uses thereof. Described herein are compounds or conjugates of For...
Invention Cereblon ligands and uses thereof. e.ge.g., as cereblon-binding agents or bifunctional degraders ...
Invention Bicyclic heteroaryl-containing compounds as ikzf2 degraders. Described herein are compounds of Fo...
G/S Downloadable computer software for use in the field of drug discovery, screenings, and pharmaceut...
G/S Downloadable computer software for use in the field of drug discovery, screenings, and pharmaceu...
2022 G/S Downloadable computer software for drug discovery, screenings, and providing pharmaceuticals; dow...